Anualidad
Event
Entity
Process
Conference
Occurrent
14.SINGLE-AGENT CETUXIMAB AS FIRST-LINE TREATMENT FOR ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER. PRELIMINARY RESULTS OF A TTD PHASE II STUDY
RDF description of 31st ESMO Congress - http://research.umh.es/vivo/pub/congreso/50191